Company profile PHAT
After 34 days of this quarter the interest is at 211.0. Based on that we can calculate that during remaining 58 days it will total up to 571.0. Phathom Pharmaceuticals -stock expected interest is significantly higher compared to previous quarter (+61.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 73 |
| 2019 | 110 50.7% QoQ | 121 10.0% QoQ | 52 -57.0% QoQ | 239 227.4% YoY 359.6% QoQ |
| 2020 | 335 204.5% YoY 40.2% QoQ | 73 -39.7% YoY -78.2% QoQ | 220 323.1% YoY 201.4% QoQ | 195 -18.4% YoY -11.4% QoQ |
| 2021 | 284 -15.2% YoY 45.6% QoQ | 184 152.1% YoY -35.2% QoQ | 204 -7.3% YoY 10.9% QoQ | 161 -17.4% YoY -21.1% QoQ |
| 2022 | 141 -50.4% YoY -12.4% QoQ | 384 108.7% YoY 172.3% QoQ | 240 17.6% YoY -37.5% QoQ | 425 164.0% YoY 77.1% QoQ |
| 2023 | 369 161.7% YoY -13.2% QoQ | 221 -42.4% YoY -40.1% QoQ | 353 47.1% YoY 59.7% QoQ | 211 -50.4% YoY -40.2% QoQ |
The average 5 years interest of Phathom Pharmaceuticals -stock was 17.61 per week. The last year interest of Phathom Pharmaceuticals -stock compared to the last 5 years has changed by 47.64%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 180.47%.
There is not enough data for Phathom Pharmaceuticals login to provide analysis
There is not enough data for Phathom Pharmaceuticals login to provide correlation calculation
There is not enough data for Phathom Pharmaceuticals login to provide analysis
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. Phathom Pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 46 | 70 52.2% QoQ | 121 72.9% QoQ | 333 175.2% QoQ |
| 2020 | 29 -37.0% YoY -91.3% QoQ | 43 -38.6% YoY 48.3% QoQ | 91 -24.8% YoY 111.6% QoQ | 30 -91.0% YoY -67.0% QoQ |
| 2021 | 44 51.7% YoY 46.7% QoQ | 85 97.7% YoY 93.2% QoQ | 177 94.5% YoY 108.2% QoQ | 128 326.7% YoY -27.7% QoQ |
| 2022 | 36 -18.2% YoY -71.9% QoQ | 54 -36.5% YoY 50.0% QoQ | 235 32.8% YoY 335.2% QoQ | 92 -28.1% YoY -60.9% QoQ |
| 2023 | 152 322.2% YoY 65.2% QoQ | 111 105.6% YoY -27.0% QoQ | 71 -69.8% YoY -36.0% QoQ | 69 -25.0% YoY -2.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Phathom Pharmaceuticals news was 7.76 per week. The last year interest of Phathom Pharmaceuticals news compared to the last 5 years has changed by -14.05%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -39.14%.
There is not enough data for P-CAB drug to provide analysis
There is not enough data for P-CAB drug to provide correlation calculation
There is not enough data for P-CAB drug to provide analysis
There is not enough data for vonoprazan drug to provide analysis
There is not enough data for vonoprazan drug to provide correlation calculation
There is not enough data for vonoprazan drug to provide analysis
There is not enough data for erosive gastroesophageal reflux disease treatment to provide analysis
There is not enough data for erosive gastroesophageal reflux disease treatment to provide correlation calculation
There is not enough data for erosive gastroesophageal reflux disease treatment to provide analysis
After 38 days of this quarter the interest is at 129.0. Based on that we can calculate that during remaining 53 days it will total up to 309.0. Helicobacter pylori infection treatment expected interest is significantly higher compared to previous quarter (+47.8%) and same quarter last year (+113.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 95 | 145 52.6% QoQ | 157 8.3% QoQ | 144 -8.3% QoQ |
| 2020 | 128 34.7% YoY -11.1% QoQ | 70 -51.7% YoY -45.3% QoQ | 88 -43.9% YoY 25.7% QoQ | 206 43.1% YoY 134.1% QoQ |
| 2021 | 200 56.2% YoY -2.9% QoQ | 147 110.0% YoY -26.5% QoQ | 155 76.1% YoY 5.4% QoQ | 313 51.9% YoY 101.9% QoQ |
| 2022 | 328 64.0% YoY 4.8% QoQ | 113 -23.1% YoY -65.5% QoQ | 129 -16.8% YoY 14.2% QoQ | 250 -20.1% YoY 93.8% QoQ |
| 2023 | 145 -55.8% YoY -42.0% QoQ | 128 13.3% YoY -11.7% QoQ | 309 139.5% YoY 141.4% QoQ | 209 -16.4% YoY -32.4% QoQ |
| 2024 | 129 -11.0% YoY -38.3% QoQ | - | - | - |
The average 5 years interest of Helicobacter pylori infection treatment was 13.8 per week. The last year interest of Helicobacter pylori infection treatment compared to the last 5 years has changed by 15.51%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 53.27%.
There is not enough data for Phathom Pharmaceuticals headquarters to provide analysis
There is not enough data for Phathom Pharmaceuticals headquarters to provide correlation calculation
There is not enough data for Phathom Pharmaceuticals headquarters to provide analysis
There is not enough data for Phathom Pharmaceuticals stock price to provide analysis
There is not enough data for Phathom Pharmaceuticals stock price to provide correlation calculation
There is not enough data for Phathom Pharmaceuticals stock price to provide analysis